Elite in Osteosarcoma

Alessandra Longhi

Istituti Ortopedici Rizzoli
Bologna, IT 
Clinical Trials:Currently Recruiting for 2 Trials
Elite in Osteosarcoma
Istituti Ortopedici Rizzoli
Bologna, IT 
OverviewLocationsClinical Research

Overview

Alessandra Longhi practices in Bologna, Italy. Ms. Longhi is rated as an Elite expert by MediFind in the treatment of Osteosarcoma. Her top areas of expertise are Osteosarcoma, Ewing Sarcoma, Adult Soft Tissue Sarcoma, and Lung Metastases.

Her clinical research consists of co-authoring 80 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 49 articles in the study of Osteosarcoma.

Gender
Female

Locations

Istituti Ortopedici Rizzoli
Bologna, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized Phase II Trial Comparing the Activity of trabectedIn vs Gemcitabine in Patients With Metastatic or Locally Advanced Leiomyosarcoma Pretreated With Conventional Chemotherapy
A Randomized Phase II Trial Comparing the Activity of trabectedIn vs Gemcitabine in Patients With Metastatic or Locally Advanced Leiomyosarcoma Pretreated With Conventional Chemotherapy
Enrollment Status: Recruiting
Publish Date: December 20, 2024
Intervention Type: Drug
Study Drugs: Trabectedin, Gemcitabine
Study Phase: Phase 2
Phase II Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Phase II Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Enrollment Status: Recruiting
Publish Date: December 20, 2024
Intervention Type: Drug
Study Drug: Trabectedin
Study Phase: Phase 2
A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: March 02, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

80 Total Publications

Multimodal treatment with cisplatin for metastatic disease in malignant peripheral nerve sheath tumors: a case report and review.
Multimodal treatment with cisplatin for metastatic disease in malignant peripheral nerve sheath tumors: a case report and review.
Journal: Anti-cancer drugs
Published: May 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Longhi's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile